Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells

We have previously demonstrated doxorubicin-induced urokinase (uPA) and interleukin-8 (IL-8) expression in human H69 small-cell lung carcinoma (SCLC) cells by a microarray technique using Human Cancer Chip version 2, in which 425 human "cancer-related" genes are spotted on the plates. The...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer chemotherapy and pharmacology 2003-11, Vol.52 (5), p.391-398
Hauptverfasser: Niiya, Masami, Niiya, Kenji, Kiguchi, Toru, Shibakura, Misako, Asaumi, Noboru, Shinagawa, Katsuji, Ishimaru, Fumihiko, Kiura, Katsuyuki, Ikeda, Kazuma, Ueoka, Hiroshi, Tanimoto, Mitsune
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 398
container_issue 5
container_start_page 391
container_title Cancer chemotherapy and pharmacology
container_volume 52
creator Niiya, Masami
Niiya, Kenji
Kiguchi, Toru
Shibakura, Misako
Asaumi, Noboru
Shinagawa, Katsuji
Ishimaru, Fumihiko
Kiura, Katsuyuki
Ikeda, Kazuma
Ueoka, Hiroshi
Tanimoto, Mitsune
description We have previously demonstrated doxorubicin-induced urokinase (uPA) and interleukin-8 (IL-8) expression in human H69 small-cell lung carcinoma (SCLC) cells by a microarray technique using Human Cancer Chip version 2, in which 425 human "cancer-related" genes are spotted on the plates. The microarray analysis also revealed a significant induction of tumor necrosis factor-alpha (TNF-alpha), and doxorubicin-induced macrophage chemoattractant protein-1 (MCP-1) expression was demonstrated by an RNase protection assay. We extended the study by testing the effects of doxorubicin on the induction of TNF-alpha, uPA, IL-8 and MCP-1 in other types of lung carcinoma cells. We investigated the effects of doxorubicin on the expression of TNF-alpha, uPA, IL-8 and MCP-1 in 12 human lung carcinoma cell lines, including five SCLC, three adenocarcinoma and four squamous cell carcinoma cells. The surface expression of their receptors was also investigated. TNF-alpha was significantly induced in three cell lines, H69, SBC-7 (SCLC) and PC-9 (adenocarcinoma), uPA in five cell lines, H69, SBC-7, EBC-1 (squamous cell), EBC-2 (squamous cell), and Sq-1 (squamous cell), IL-8 in three cell lines, H69, PC-9 and EBC-1, and MCP-1 in five cell lines, H69, SBC-3 (SCLC), SBC-7, PC-9 and Sq-1. In H69 cells, TNF-alpha antigen levels were increased approximately fivefold in the conditioned medium of doxorubicin-treated cells, in parallel with an increase in mRNA levels. As with uPA and IL-8, the maximum induction was observed at the "sublethal" concentrations of 2 and 4 microM at which cell growth was slightly inhibited 24 h after treatment. Furthermore, the cells did not express receptors including types I and II TNF-alpha receptors, uPA receptor (uPAR), C-x-C-chemokine receptor-1 (CXCR-1), or C-C-chemokine receptor-2, corresponding to TNF-alpha, uPA, IL-8 and MCP-1, respectively, that were induced by doxorubicin in the cells, although SBC-7 cells expressed uPAR, and EBC-1 cells expressed CXCR-1. TNF-alpha, uPA, IL-8 and MCP-1 induced and secreted from tumor cells upon doxorubicin stimulation may activate surrounding cells expressing the receptors such as neutrophils and monocytes/macrophages in a paracrine fashion. TNF-alpha is a major proinflammatory cytokine, and IL-8 and MCP-1 are major chemoattractants for neutrophils and monocytes/macrophages, respectively. Furthermore, uPA activates matrix metalloproteinase 9 which can truncate and activate IL-8. Thus, the simultaneous induction of TNF
doi_str_mv 10.1007/s00280-003-0665-1
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_213496314</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>689862201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1834-fe88abd003b632e520f0f749c51a36b3fe1563a72d13312439ae54093cfa726e3</originalsourceid><addsrcrecordid>eNotkE1LAzEQhoMoWKs_wFvw3Ogkk_06SSlWC1V7qOeQzSa6ZbupSRfaf29KhYGBl5eZh4eQew6PHKB4igCiBAaADPI8Y_yCjLhEwaCUeElGgFKyrAB5TW5i3ACA5Igjsl70zWD2re-pd3T9MWfPEzqsphO6WLKS6r6h77MV47Q-0sYffBjq1rQ9TfMzbHVPu6H_pkaHFPqtpsZ2XbwlV0530d797zH5mr-sZ29s-fm6mE2XzPASJXO2LHXdJOY6R2EzAQ5cISuTcY15jc7yLEddiCahciGx0jaTUKFxKcwtjsnD-e4u-N_Bxr3a-CH06aUSHGWVY1IwJvxcMsHHGKxTu9BudTgqDurkTp3dqcShTu4Uxz_XAF23</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>213496314</pqid></control><display><type>article</type><title>Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells</title><source>SpringerLink Journals - AutoHoldings</source><creator>Niiya, Masami ; Niiya, Kenji ; Kiguchi, Toru ; Shibakura, Misako ; Asaumi, Noboru ; Shinagawa, Katsuji ; Ishimaru, Fumihiko ; Kiura, Katsuyuki ; Ikeda, Kazuma ; Ueoka, Hiroshi ; Tanimoto, Mitsune</creator><creatorcontrib>Niiya, Masami ; Niiya, Kenji ; Kiguchi, Toru ; Shibakura, Misako ; Asaumi, Noboru ; Shinagawa, Katsuji ; Ishimaru, Fumihiko ; Kiura, Katsuyuki ; Ikeda, Kazuma ; Ueoka, Hiroshi ; Tanimoto, Mitsune</creatorcontrib><description>We have previously demonstrated doxorubicin-induced urokinase (uPA) and interleukin-8 (IL-8) expression in human H69 small-cell lung carcinoma (SCLC) cells by a microarray technique using Human Cancer Chip version 2, in which 425 human "cancer-related" genes are spotted on the plates. The microarray analysis also revealed a significant induction of tumor necrosis factor-alpha (TNF-alpha), and doxorubicin-induced macrophage chemoattractant protein-1 (MCP-1) expression was demonstrated by an RNase protection assay. We extended the study by testing the effects of doxorubicin on the induction of TNF-alpha, uPA, IL-8 and MCP-1 in other types of lung carcinoma cells. We investigated the effects of doxorubicin on the expression of TNF-alpha, uPA, IL-8 and MCP-1 in 12 human lung carcinoma cell lines, including five SCLC, three adenocarcinoma and four squamous cell carcinoma cells. The surface expression of their receptors was also investigated. TNF-alpha was significantly induced in three cell lines, H69, SBC-7 (SCLC) and PC-9 (adenocarcinoma), uPA in five cell lines, H69, SBC-7, EBC-1 (squamous cell), EBC-2 (squamous cell), and Sq-1 (squamous cell), IL-8 in three cell lines, H69, PC-9 and EBC-1, and MCP-1 in five cell lines, H69, SBC-3 (SCLC), SBC-7, PC-9 and Sq-1. In H69 cells, TNF-alpha antigen levels were increased approximately fivefold in the conditioned medium of doxorubicin-treated cells, in parallel with an increase in mRNA levels. As with uPA and IL-8, the maximum induction was observed at the "sublethal" concentrations of 2 and 4 microM at which cell growth was slightly inhibited 24 h after treatment. Furthermore, the cells did not express receptors including types I and II TNF-alpha receptors, uPA receptor (uPAR), C-x-C-chemokine receptor-1 (CXCR-1), or C-C-chemokine receptor-2, corresponding to TNF-alpha, uPA, IL-8 and MCP-1, respectively, that were induced by doxorubicin in the cells, although SBC-7 cells expressed uPAR, and EBC-1 cells expressed CXCR-1. TNF-alpha, uPA, IL-8 and MCP-1 induced and secreted from tumor cells upon doxorubicin stimulation may activate surrounding cells expressing the receptors such as neutrophils and monocytes/macrophages in a paracrine fashion. TNF-alpha is a major proinflammatory cytokine, and IL-8 and MCP-1 are major chemoattractants for neutrophils and monocytes/macrophages, respectively. Furthermore, uPA activates matrix metalloproteinase 9 which can truncate and activate IL-8. Thus, the simultaneous induction of TNF-alpha, uPA, IL-8 and MCP-1 may enhance the interaction between tumor and inflammatory/immune cells, and augment cytotoxicity.</description><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/s00280-003-0665-1</identifier><language>eng</language><publisher>Heidelberg: Springer Nature B.V</publisher><ispartof>Cancer chemotherapy and pharmacology, 2003-11, Vol.52 (5), p.391-398</ispartof><rights>Copyright Springer-Verlag 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1834-fe88abd003b632e520f0f749c51a36b3fe1563a72d13312439ae54093cfa726e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Niiya, Masami</creatorcontrib><creatorcontrib>Niiya, Kenji</creatorcontrib><creatorcontrib>Kiguchi, Toru</creatorcontrib><creatorcontrib>Shibakura, Misako</creatorcontrib><creatorcontrib>Asaumi, Noboru</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Ishimaru, Fumihiko</creatorcontrib><creatorcontrib>Kiura, Katsuyuki</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Ueoka, Hiroshi</creatorcontrib><creatorcontrib>Tanimoto, Mitsune</creatorcontrib><title>Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells</title><title>Cancer chemotherapy and pharmacology</title><description>We have previously demonstrated doxorubicin-induced urokinase (uPA) and interleukin-8 (IL-8) expression in human H69 small-cell lung carcinoma (SCLC) cells by a microarray technique using Human Cancer Chip version 2, in which 425 human "cancer-related" genes are spotted on the plates. The microarray analysis also revealed a significant induction of tumor necrosis factor-alpha (TNF-alpha), and doxorubicin-induced macrophage chemoattractant protein-1 (MCP-1) expression was demonstrated by an RNase protection assay. We extended the study by testing the effects of doxorubicin on the induction of TNF-alpha, uPA, IL-8 and MCP-1 in other types of lung carcinoma cells. We investigated the effects of doxorubicin on the expression of TNF-alpha, uPA, IL-8 and MCP-1 in 12 human lung carcinoma cell lines, including five SCLC, three adenocarcinoma and four squamous cell carcinoma cells. The surface expression of their receptors was also investigated. TNF-alpha was significantly induced in three cell lines, H69, SBC-7 (SCLC) and PC-9 (adenocarcinoma), uPA in five cell lines, H69, SBC-7, EBC-1 (squamous cell), EBC-2 (squamous cell), and Sq-1 (squamous cell), IL-8 in three cell lines, H69, PC-9 and EBC-1, and MCP-1 in five cell lines, H69, SBC-3 (SCLC), SBC-7, PC-9 and Sq-1. In H69 cells, TNF-alpha antigen levels were increased approximately fivefold in the conditioned medium of doxorubicin-treated cells, in parallel with an increase in mRNA levels. As with uPA and IL-8, the maximum induction was observed at the "sublethal" concentrations of 2 and 4 microM at which cell growth was slightly inhibited 24 h after treatment. Furthermore, the cells did not express receptors including types I and II TNF-alpha receptors, uPA receptor (uPAR), C-x-C-chemokine receptor-1 (CXCR-1), or C-C-chemokine receptor-2, corresponding to TNF-alpha, uPA, IL-8 and MCP-1, respectively, that were induced by doxorubicin in the cells, although SBC-7 cells expressed uPAR, and EBC-1 cells expressed CXCR-1. TNF-alpha, uPA, IL-8 and MCP-1 induced and secreted from tumor cells upon doxorubicin stimulation may activate surrounding cells expressing the receptors such as neutrophils and monocytes/macrophages in a paracrine fashion. TNF-alpha is a major proinflammatory cytokine, and IL-8 and MCP-1 are major chemoattractants for neutrophils and monocytes/macrophages, respectively. Furthermore, uPA activates matrix metalloproteinase 9 which can truncate and activate IL-8. Thus, the simultaneous induction of TNF-alpha, uPA, IL-8 and MCP-1 may enhance the interaction between tumor and inflammatory/immune cells, and augment cytotoxicity.</description><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNotkE1LAzEQhoMoWKs_wFvw3Ogkk_06SSlWC1V7qOeQzSa6ZbupSRfaf29KhYGBl5eZh4eQew6PHKB4igCiBAaADPI8Y_yCjLhEwaCUeElGgFKyrAB5TW5i3ACA5Igjsl70zWD2re-pd3T9MWfPEzqsphO6WLKS6r6h77MV47Q-0sYffBjq1rQ9TfMzbHVPu6H_pkaHFPqtpsZ2XbwlV0530d797zH5mr-sZ29s-fm6mE2XzPASJXO2LHXdJOY6R2EzAQ5cISuTcY15jc7yLEddiCahciGx0jaTUKFxKcwtjsnD-e4u-N_Bxr3a-CH06aUSHGWVY1IwJvxcMsHHGKxTu9BudTgqDurkTp3dqcShTu4Uxz_XAF23</recordid><startdate>20031101</startdate><enddate>20031101</enddate><creator>Niiya, Masami</creator><creator>Niiya, Kenji</creator><creator>Kiguchi, Toru</creator><creator>Shibakura, Misako</creator><creator>Asaumi, Noboru</creator><creator>Shinagawa, Katsuji</creator><creator>Ishimaru, Fumihiko</creator><creator>Kiura, Katsuyuki</creator><creator>Ikeda, Kazuma</creator><creator>Ueoka, Hiroshi</creator><creator>Tanimoto, Mitsune</creator><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20031101</creationdate><title>Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells</title><author>Niiya, Masami ; Niiya, Kenji ; Kiguchi, Toru ; Shibakura, Misako ; Asaumi, Noboru ; Shinagawa, Katsuji ; Ishimaru, Fumihiko ; Kiura, Katsuyuki ; Ikeda, Kazuma ; Ueoka, Hiroshi ; Tanimoto, Mitsune</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1834-fe88abd003b632e520f0f749c51a36b3fe1563a72d13312439ae54093cfa726e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niiya, Masami</creatorcontrib><creatorcontrib>Niiya, Kenji</creatorcontrib><creatorcontrib>Kiguchi, Toru</creatorcontrib><creatorcontrib>Shibakura, Misako</creatorcontrib><creatorcontrib>Asaumi, Noboru</creatorcontrib><creatorcontrib>Shinagawa, Katsuji</creatorcontrib><creatorcontrib>Ishimaru, Fumihiko</creatorcontrib><creatorcontrib>Kiura, Katsuyuki</creatorcontrib><creatorcontrib>Ikeda, Kazuma</creatorcontrib><creatorcontrib>Ueoka, Hiroshi</creatorcontrib><creatorcontrib>Tanimoto, Mitsune</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niiya, Masami</au><au>Niiya, Kenji</au><au>Kiguchi, Toru</au><au>Shibakura, Misako</au><au>Asaumi, Noboru</au><au>Shinagawa, Katsuji</au><au>Ishimaru, Fumihiko</au><au>Kiura, Katsuyuki</au><au>Ikeda, Kazuma</au><au>Ueoka, Hiroshi</au><au>Tanimoto, Mitsune</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><date>2003-11-01</date><risdate>2003</risdate><volume>52</volume><issue>5</issue><spage>391</spage><epage>398</epage><pages>391-398</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><abstract>We have previously demonstrated doxorubicin-induced urokinase (uPA) and interleukin-8 (IL-8) expression in human H69 small-cell lung carcinoma (SCLC) cells by a microarray technique using Human Cancer Chip version 2, in which 425 human "cancer-related" genes are spotted on the plates. The microarray analysis also revealed a significant induction of tumor necrosis factor-alpha (TNF-alpha), and doxorubicin-induced macrophage chemoattractant protein-1 (MCP-1) expression was demonstrated by an RNase protection assay. We extended the study by testing the effects of doxorubicin on the induction of TNF-alpha, uPA, IL-8 and MCP-1 in other types of lung carcinoma cells. We investigated the effects of doxorubicin on the expression of TNF-alpha, uPA, IL-8 and MCP-1 in 12 human lung carcinoma cell lines, including five SCLC, three adenocarcinoma and four squamous cell carcinoma cells. The surface expression of their receptors was also investigated. TNF-alpha was significantly induced in three cell lines, H69, SBC-7 (SCLC) and PC-9 (adenocarcinoma), uPA in five cell lines, H69, SBC-7, EBC-1 (squamous cell), EBC-2 (squamous cell), and Sq-1 (squamous cell), IL-8 in three cell lines, H69, PC-9 and EBC-1, and MCP-1 in five cell lines, H69, SBC-3 (SCLC), SBC-7, PC-9 and Sq-1. In H69 cells, TNF-alpha antigen levels were increased approximately fivefold in the conditioned medium of doxorubicin-treated cells, in parallel with an increase in mRNA levels. As with uPA and IL-8, the maximum induction was observed at the "sublethal" concentrations of 2 and 4 microM at which cell growth was slightly inhibited 24 h after treatment. Furthermore, the cells did not express receptors including types I and II TNF-alpha receptors, uPA receptor (uPAR), C-x-C-chemokine receptor-1 (CXCR-1), or C-C-chemokine receptor-2, corresponding to TNF-alpha, uPA, IL-8 and MCP-1, respectively, that were induced by doxorubicin in the cells, although SBC-7 cells expressed uPAR, and EBC-1 cells expressed CXCR-1. TNF-alpha, uPA, IL-8 and MCP-1 induced and secreted from tumor cells upon doxorubicin stimulation may activate surrounding cells expressing the receptors such as neutrophils and monocytes/macrophages in a paracrine fashion. TNF-alpha is a major proinflammatory cytokine, and IL-8 and MCP-1 are major chemoattractants for neutrophils and monocytes/macrophages, respectively. Furthermore, uPA activates matrix metalloproteinase 9 which can truncate and activate IL-8. Thus, the simultaneous induction of TNF-alpha, uPA, IL-8 and MCP-1 may enhance the interaction between tumor and inflammatory/immune cells, and augment cytotoxicity.</abstract><cop>Heidelberg</cop><pub>Springer Nature B.V</pub><doi>10.1007/s00280-003-0665-1</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0344-5704
ispartof Cancer chemotherapy and pharmacology, 2003-11, Vol.52 (5), p.391-398
issn 0344-5704
1432-0843
language eng
recordid cdi_proquest_journals_213496314
source SpringerLink Journals - AutoHoldings
title Induction of TNF-?, uPA, IL-8 and MCP-1 by doxorubicin in human lung carcinoma cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T23%3A45%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Induction%20of%20TNF-?,%20uPA,%20IL-8%20and%20MCP-1%20by%20doxorubicin%20in%20human%20lung%20carcinoma%20cells&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=Niiya,%20Masami&rft.date=2003-11-01&rft.volume=52&rft.issue=5&rft.spage=391&rft.epage=398&rft.pages=391-398&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/s00280-003-0665-1&rft_dat=%3Cproquest_cross%3E689862201%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=213496314&rft_id=info:pmid/&rfr_iscdi=true